Together, our results identify a pathway, EZH2-miR-361-Twist, that positive regulates tumor malignancy by promoting cancer cell proliferation, invasion, and self-renewal, and further support EZH2 as a promising therapeutic anti-EC target. Here, EZH2 is linked to cancer.